Industry Research Reports
Home > Reports > Service & Software > Hemocompatibility Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Hemocompatibility Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Service & Software
Published Date: 2025-06-07
Pages: 134 Pages
Report ld: 4757088
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemocompatibility Testing Service Market Size(US$)
CAGR 2025-2031
7.3%
Market Size,2031
USD 139
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 91 million
Market Forecast in 2031(Value)
US$ 139 million
CAGR
7.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Hemocompatibility Testing Service was estimated to be worth US$ 83.0 million in 2024 and is forecast to a readjusted size of US$ 139 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Hemocompatibility testing service refers to a specialized analytical evaluation conducted to assess how biological materials, medical devices, or pharmaceuticals interact with blood components, ensuring they do not trigger adverse reactions such as thrombosis, hemolysis, inflammation, or immune responses. This service involves in vitro (test tube) and sometimes in vivo (animal model) assessments to measure parameters like blood cell adhesion, platelet activation, complement system activation, and coagulation factor disruption. It is crucial for the development and regulatory approval of medical products such as implants, catheters, artificial organs, or drug delivery systems, as non-hemocompatible materials can lead to life-threatening complications in patients. By simulating physiological conditions, these tests help manufacturers and researchers validate the safety of materials before human use, ensuring they integrate with the body’s circulatory system without compromising blood integrity or function.
North American market for Hemocompatibility Testing Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hemocompatibility Testing Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Hemocompatibility Testing Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Hemocompatibility Testing Service include Matexcel, Eurofins, Nelson Laboratories, LLC, Haemoscan, Measurlabs, STEMart, NAMSA, Lupine Medical, Eurolab, Nucro-Technics, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Hemocompatibility Testing Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Hemocompatibility Testing Service by region & country, by Type, and by Application.
The Hemocompatibility Testing Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemocompatibility Testing Service.
MARKET SEGMENTATION
By Company
- Matexcel
- Eurofins
- Nelson Laboratories, LLC
- Haemoscan
- Measurlabs
- STEMart
- NAMSA
- Lupine Medical
- Eurolab
- Nucro-Technics
- TÜV SÜD
- Eucerep
- UL Solutions
- Level Biotechnology Inc.
- Cosmos Biomed Consulting
- Charles River Laboratories
- Ceshigo
- Kerbio
- Weike Inspection Group
- CTI
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Hemolysis Testing
- Complement Activation Testing
- Platelet Activation Testing
- Thrombogenicity Testing
- Coagulation Testing
- Others
Segment by Application
- Medical Device Development
- Biomedical Materials Research
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hemocompatibility Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Hemocompatibility Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Hemocompatibility Testing Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hemocompatibility Testing Service Product Introduction
1.2 Global Hemocompatibility Testing Service Market Size Forecast (2020-2031)
1.3 Hemocompatibility Testing Service Market Trends & Drivers
1.3.1 Hemocompatibility Testing Service Industry Trends
1.3.2 Hemocompatibility Testing Service Market Drivers & Opportunity
1.3.3 Hemocompatibility Testing Service Market Challenges
1.3.4 Hemocompatibility Testing Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hemocompatibility Testing Service Players Revenue Ranking (2024)
2.2 Global Hemocompatibility Testing Service Revenue by Company (2020-2025)
2.3 Key Companies Hemocompatibility Testing Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Hemocompatibility Testing Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Hemocompatibility Testing Service
2.6 Hemocompatibility Testing Service Market Competitive Analysis
2.6.1 Hemocompatibility Testing Service Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Hemocompatibility Testing Service Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemocompatibility Testing Service as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hemolysis Testing
3.1.2 Complement Activation Testing
3.1.3 Platelet Activation Testing
3.1.4 Thrombogenicity Testing
3.1.5 Coagulation Testing
3.1.6 Others
3.2 Global Hemocompatibility Testing Service Sales Value by Type
3.2.1 Global Hemocompatibility Testing Service Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Hemocompatibility Testing Service Sales Value, by Type (2020-2031)
3.2.3 Global Hemocompatibility Testing Service Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical Device Development
4.1.2 Biomedical Materials Research
4.1.3 Others
4.2 Global Hemocompatibility Testing Service Sales Value by Application
4.2.1 Global Hemocompatibility Testing Service Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Hemocompatibility Testing Service Sales Value, by Application (2020-2031)
4.2.3 Global Hemocompatibility Testing Service Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Hemocompatibility Testing Service Sales Value by Region
5.1.1 Global Hemocompatibility Testing Service Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Hemocompatibility Testing Service Sales Value by Region (2020-2025)
5.1.3 Global Hemocompatibility Testing Service Sales Value by Region (2026-2031)
5.1.4 Global Hemocompatibility Testing Service Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Hemocompatibility Testing Service Sales Value, 2020-2031
5.2.2 North America Hemocompatibility Testing Service Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Hemocompatibility Testing Service Sales Value, 2020-2031
5.3.2 Europe Hemocompatibility Testing Service Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Hemocompatibility Testing Service Sales Value, 2020-2031
5.4.2 Asia Pacific Hemocompatibility Testing Service Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Hemocompatibility Testing Service Sales Value, 2020-2031
5.5.2 South America Hemocompatibility Testing Service Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Hemocompatibility Testing Service Sales Value, 2020-2031
5.6.2 Middle East & Africa Hemocompatibility Testing Service Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hemocompatibility Testing Service Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Hemocompatibility Testing Service Sales Value, 2020-2031
6.3 United States
6.3.1 United States Hemocompatibility Testing Service Sales Value, 2020-2031
6.3.2 United States Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Hemocompatibility Testing Service Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Hemocompatibility Testing Service Sales Value, 2020-2031
6.4.2 Europe Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Hemocompatibility Testing Service Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Hemocompatibility Testing Service Sales Value, 2020-2031
6.5.2 China Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
6.5.3 China Hemocompatibility Testing Service Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Hemocompatibility Testing Service Sales Value, 2020-2031
6.6.2 Japan Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Hemocompatibility Testing Service Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Hemocompatibility Testing Service Sales Value, 2020-2031
6.7.2 South Korea Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Hemocompatibility Testing Service Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Hemocompatibility Testing Service Sales Value, 2020-2031
6.8.2 Southeast Asia Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Hemocompatibility Testing Service Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Hemocompatibility Testing Service Sales Value, 2020-2031
6.9.2 India Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
6.9.3 India Hemocompatibility Testing Service Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Matexcel
7.1.1 Matexcel Profile
7.1.2 Matexcel Main Business
7.1.3 Matexcel Hemocompatibility Testing Service Products, Services and Solutions
7.1.4 Matexcel Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.1.5 Matexcel Recent Developments
7.2 Eurofins
7.2.1 Eurofins Profile
7.2.2 Eurofins Main Business
7.2.3 Eurofins Hemocompatibility Testing Service Products, Services and Solutions
7.2.4 Eurofins Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.2.5 Eurofins Recent Developments
7.3 Nelson Laboratories, LLC
7.3.1 Nelson Laboratories, LLC Profile
7.3.2 Nelson Laboratories, LLC Main Business
7.3.3 Nelson Laboratories, LLC Hemocompatibility Testing Service Products, Services and Solutions
7.3.4 Nelson Laboratories, LLC Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.3.5 Nelson Laboratories, LLC Recent Developments
7.4 Haemoscan
7.4.1 Haemoscan Profile
7.4.2 Haemoscan Main Business
7.4.3 Haemoscan Hemocompatibility Testing Service Products, Services and Solutions
7.4.4 Haemoscan Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.4.5 Haemoscan Recent Developments
7.5 Measurlabs
7.5.1 Measurlabs Profile
7.5.2 Measurlabs Main Business
7.5.3 Measurlabs Hemocompatibility Testing Service Products, Services and Solutions
7.5.4 Measurlabs Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.5.5 Measurlabs Recent Developments
7.6 STEMart
7.6.1 STEMart Profile
7.6.2 STEMart Main Business
7.6.3 STEMart Hemocompatibility Testing Service Products, Services and Solutions
7.6.4 STEMart Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.6.5 STEMart Recent Developments
7.7 NAMSA
7.7.1 NAMSA Profile
7.7.2 NAMSA Main Business
7.7.3 NAMSA Hemocompatibility Testing Service Products, Services and Solutions
7.7.4 NAMSA Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.7.5 NAMSA Recent Developments
7.8 Lupine Medical
7.8.1 Lupine Medical Profile
7.8.2 Lupine Medical Main Business
7.8.3 Lupine Medical Hemocompatibility Testing Service Products, Services and Solutions
7.8.4 Lupine Medical Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.8.5 Lupine Medical Recent Developments
7.9 Eurolab
7.9.1 Eurolab Profile
7.9.2 Eurolab Main Business
7.9.3 Eurolab Hemocompatibility Testing Service Products, Services and Solutions
7.9.4 Eurolab Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.9.5 Eurolab Recent Developments
7.10 Nucro-Technics
7.10.1 Nucro-Technics Profile
7.10.2 Nucro-Technics Main Business
7.10.3 Nucro-Technics Hemocompatibility Testing Service Products, Services and Solutions
7.10.4 Nucro-Technics Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.10.5 Nucro-Technics Recent Developments
7.11 TÜV SÜD
7.11.1 TÜV SÜD Profile
7.11.2 TÜV SÜD Main Business
7.11.3 TÜV SÜD Hemocompatibility Testing Service Products, Services and Solutions
7.11.4 TÜV SÜD Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.11.5 TÜV SÜD Recent Developments
7.12 Eucerep
7.12.1 Eucerep Profile
7.12.2 Eucerep Main Business
7.12.3 Eucerep Hemocompatibility Testing Service Products, Services and Solutions
7.12.4 Eucerep Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.12.5 Eucerep Recent Developments
7.13 UL Solutions
7.13.1 UL Solutions Profile
7.13.2 UL Solutions Main Business
7.13.3 UL Solutions Hemocompatibility Testing Service Products, Services and Solutions
7.13.4 UL Solutions Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.13.5 UL Solutions Recent Developments
7.14 Level Biotechnology Inc.
7.14.1 Level Biotechnology Inc. Profile
7.14.2 Level Biotechnology Inc. Main Business
7.14.3 Level Biotechnology Inc. Hemocompatibility Testing Service Products, Services and Solutions
7.14.4 Level Biotechnology Inc. Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.14.5 Level Biotechnology Inc. Recent Developments
7.15 Cosmos Biomed Consulting
7.15.1 Cosmos Biomed Consulting Profile
7.15.2 Cosmos Biomed Consulting Main Business
7.15.3 Cosmos Biomed Consulting Hemocompatibility Testing Service Products, Services and Solutions
7.15.4 Cosmos Biomed Consulting Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.15.5 Cosmos Biomed Consulting Recent Developments
7.16 Charles River Laboratories
7.16.1 Charles River Laboratories Profile
7.16.2 Charles River Laboratories Main Business
7.16.3 Charles River Laboratories Hemocompatibility Testing Service Products, Services and Solutions
7.16.4 Charles River Laboratories Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.16.5 Charles River Laboratories Recent Developments
7.17 Ceshigo
7.17.1 Ceshigo Profile
7.17.2 Ceshigo Main Business
7.17.3 Ceshigo Hemocompatibility Testing Service Products, Services and Solutions
7.17.4 Ceshigo Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.17.5 Ceshigo Recent Developments
7.18 Kerbio
7.18.1 Kerbio Profile
7.18.2 Kerbio Main Business
7.18.3 Kerbio Hemocompatibility Testing Service Products, Services and Solutions
7.18.4 Kerbio Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.18.5 Kerbio Recent Developments
7.19 Weike Inspection Group
7.19.1 Weike Inspection Group Profile
7.19.2 Weike Inspection Group Main Business
7.19.3 Weike Inspection Group Hemocompatibility Testing Service Products, Services and Solutions
7.19.4 Weike Inspection Group Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.19.5 Weike Inspection Group Recent Developments
7.20 CTI
7.20.1 CTI Profile
7.20.2 CTI Main Business
7.20.3 CTI Hemocompatibility Testing Service Products, Services and Solutions
7.20.4 CTI Hemocompatibility Testing Service Revenue (US$ Million) & (2020-2025)
7.20.5 CTI Recent Developments
8 Industry Chain Analysis
8.1 Hemocompatibility Testing Service Industrial Chain
8.2 Hemocompatibility Testing Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hemocompatibility Testing Service Sales Model
8.5.2 Sales Channel
8.5.3 Hemocompatibility Testing Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Hemocompatibility Testing Service Market Trends
Table 2. Hemocompatibility Testing Service Market Drivers & Opportunity
Table 3. Hemocompatibility Testing Service Market Challenges
Table 4. Hemocompatibility Testing Service Market Restraints
Table 5. Global Hemocompatibility Testing Service Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Hemocompatibility Testing Service Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Hemocompatibility Testing Service Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Hemocompatibility Testing Service Product Type
Table 9. Key Companies Time to Begin Mass Production of Hemocompatibility Testing Service
Table 10. Global Hemocompatibility Testing Service Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemocompatibility Testing Service as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Hemocompatibility Testing Service Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Hemocompatibility Testing Service Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Hemocompatibility Testing Service Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Hemocompatibility Testing Service Sales Market Share in Value by Type (2020-2025)
Table 17. Global Hemocompatibility Testing Service Sales Market Share in Value by Type (2026-2031)
Table 18. Global Hemocompatibility Testing Service Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Hemocompatibility Testing Service Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Hemocompatibility Testing Service Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Hemocompatibility Testing Service Sales Market Share in Value by Application (2020-2025)
Table 22. Global Hemocompatibility Testing Service Sales Market Share in Value by Application (2026-2031)
Table 23. Global Hemocompatibility Testing Service Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Hemocompatibility Testing Service Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Hemocompatibility Testing Service Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Hemocompatibility Testing Service Sales Value by Region (2020-2025) & (%)
Table 27. Global Hemocompatibility Testing Service Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Hemocompatibility Testing Service Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Hemocompatibility Testing Service Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Hemocompatibility Testing Service Sales Value, (2026-2031) & (US$ Million)
Table 31. Matexcel Basic Information List
Table 32. Matexcel Description and Business Overview
Table 33. Matexcel Hemocompatibility Testing Service Products, Services and Solutions
Table 34. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Matexcel (2020-2025)
Table 35. Matexcel Recent Developments
Table 36. Eurofins Basic Information List
Table 37. Eurofins Description and Business Overview
Table 38. Eurofins Hemocompatibility Testing Service Products, Services and Solutions
Table 39. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Eurofins (2020-2025)
Table 40. Eurofins Recent Developments
Table 41. Nelson Laboratories, LLC Basic Information List
Table 42. Nelson Laboratories, LLC Description and Business Overview
Table 43. Nelson Laboratories, LLC Hemocompatibility Testing Service Products, Services and Solutions
Table 44. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Nelson Laboratories, LLC (2020-2025)
Table 45. Nelson Laboratories, LLC Recent Developments
Table 46. Haemoscan Basic Information List
Table 47. Haemoscan Description and Business Overview
Table 48. Haemoscan Hemocompatibility Testing Service Products, Services and Solutions
Table 49. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Haemoscan (2020-2025)
Table 50. Haemoscan Recent Developments
Table 51. Measurlabs Basic Information List
Table 52. Measurlabs Description and Business Overview
Table 53. Measurlabs Hemocompatibility Testing Service Products, Services and Solutions
Table 54. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Measurlabs (2020-2025)
Table 55. Measurlabs Recent Developments
Table 56. STEMart Basic Information List
Table 57. STEMart Description and Business Overview
Table 58. STEMart Hemocompatibility Testing Service Products, Services and Solutions
Table 59. Revenue (US$ Million) in Hemocompatibility Testing Service Business of STEMart (2020-2025)
Table 60. STEMart Recent Developments
Table 61. NAMSA Basic Information List
Table 62. NAMSA Description and Business Overview
Table 63. NAMSA Hemocompatibility Testing Service Products, Services and Solutions
Table 64. Revenue (US$ Million) in Hemocompatibility Testing Service Business of NAMSA (2020-2025)
Table 65. NAMSA Recent Developments
Table 66. Lupine Medical Basic Information List
Table 67. Lupine Medical Description and Business Overview
Table 68. Lupine Medical Hemocompatibility Testing Service Products, Services and Solutions
Table 69. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Lupine Medical (2020-2025)
Table 70. Lupine Medical Recent Developments
Table 71. Eurolab Basic Information List
Table 72. Eurolab Description and Business Overview
Table 73. Eurolab Hemocompatibility Testing Service Products, Services and Solutions
Table 74. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Eurolab (2020-2025)
Table 75. Eurolab Recent Developments
Table 76. Nucro-Technics Basic Information List
Table 77. Nucro-Technics Description and Business Overview
Table 78. Nucro-Technics Hemocompatibility Testing Service Products, Services and Solutions
Table 79. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Nucro-Technics (2020-2025)
Table 80. Nucro-Technics Recent Developments
Table 81. TÜV SÜD Basic Information List
Table 82. TÜV SÜD Description and Business Overview
Table 83. TÜV SÜD Hemocompatibility Testing Service Products, Services and Solutions
Table 84. Revenue (US$ Million) in Hemocompatibility Testing Service Business of TÜV SÜD (2020-2025)
Table 85. TÜV SÜD Recent Developments
Table 86. Eucerep Basic Information List
Table 87. Eucerep Description and Business Overview
Table 88. Eucerep Hemocompatibility Testing Service Products, Services and Solutions
Table 89. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Eucerep (2020-2025)
Table 90. Eucerep Recent Developments
Table 91. UL Solutions Basic Information List
Table 92. UL Solutions Description and Business Overview
Table 93. UL Solutions Hemocompatibility Testing Service Products, Services and Solutions
Table 94. Revenue (US$ Million) in Hemocompatibility Testing Service Business of UL Solutions (2020-2025)
Table 95. UL Solutions Recent Developments
Table 96. Level Biotechnology Inc. Basic Information List
Table 97. Level Biotechnology Inc. Description and Business Overview
Table 98. Level Biotechnology Inc. Hemocompatibility Testing Service Products, Services and Solutions
Table 99. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Level Biotechnology Inc. (2020-2025)
Table 100. Level Biotechnology Inc. Recent Developments
Table 101. Cosmos Biomed Consulting Basic Information List
Table 102. Cosmos Biomed Consulting Description and Business Overview
Table 103. Cosmos Biomed Consulting Hemocompatibility Testing Service Products, Services and Solutions
Table 104. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Cosmos Biomed Consulting (2020-2025)
Table 105. Cosmos Biomed Consulting Recent Developments
Table 106. Charles River Laboratories Basic Information List
Table 107. Charles River Laboratories Description and Business Overview
Table 108. Charles River Laboratories Hemocompatibility Testing Service Products, Services and Solutions
Table 109. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Charles River Laboratories (2020-2025)
Table 110. Charles River Laboratories Recent Developments
Table 111. Ceshigo Basic Information List
Table 112. Ceshigo Description and Business Overview
Table 113. Ceshigo Hemocompatibility Testing Service Products, Services and Solutions
Table 114. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Ceshigo (2020-2025)
Table 115. Ceshigo Recent Developments
Table 116. Kerbio Basic Information List
Table 117. Kerbio Description and Business Overview
Table 118. Kerbio Hemocompatibility Testing Service Products, Services and Solutions
Table 119. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Kerbio (2020-2025)
Table 120. Kerbio Recent Developments
Table 121. Weike Inspection Group Basic Information List
Table 122. Weike Inspection Group Description and Business Overview
Table 123. Weike Inspection Group Hemocompatibility Testing Service Products, Services and Solutions
Table 124. Revenue (US$ Million) in Hemocompatibility Testing Service Business of Weike Inspection Group (2020-2025)
Table 125. Weike Inspection Group Recent Developments
Table 126. CTI Basic Information List
Table 127. CTI Description and Business Overview
Table 128. CTI Hemocompatibility Testing Service Products, Services and Solutions
Table 129. Revenue (US$ Million) in Hemocompatibility Testing Service Business of CTI (2020-2025)
Table 130. CTI Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Hemocompatibility Testing Service Downstream Customers
Table 134. Hemocompatibility Testing Service Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemocompatibility Testing Service Product Picture
Figure 2. Global Hemocompatibility Testing Service Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Hemocompatibility Testing Service Sales Value (2020-2031) & (US$ Million)
Figure 4. Hemocompatibility Testing Service Report Years Considered
Figure 5. Global Hemocompatibility Testing Service Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Hemocompatibility Testing Service Revenue in 2024
Figure 7. Hemocompatibility Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Hemolysis Testing Picture
Figure 9. Complement Activation Testing Picture
Figure 10. Platelet Activation Testing Picture
Figure 11. Thrombogenicity Testing Picture
Figure 12. Coagulation Testing Picture
Figure 13. Others Picture
Figure 14. Global Hemocompatibility Testing Service Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Hemocompatibility Testing Service Sales Value Market Share by Type, 2024 & 2031
Figure 16. Product Picture of Medical Device Development
Figure 17. Product Picture of Biomedical Materials Research
Figure 18. Product Picture of Others
Figure 19. Global Hemocompatibility Testing Service Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 20. Global Hemocompatibility Testing Service Sales Value Market Share by Application, 2024 & 2031
Figure 21. North America Hemocompatibility Testing Service Sales Value (2020-2031) & (US$ Million)
Figure 22. North America Hemocompatibility Testing Service Sales Value by Country (%), 2024 VS 2031
Figure 23. Europe Hemocompatibility Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 24. Europe Hemocompatibility Testing Service Sales Value by Country (%), 2024 VS 2031
Figure 25. Asia Pacific Hemocompatibility Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 26. Asia Pacific Hemocompatibility Testing Service Sales Value by Region (%), 2024 VS 2031
Figure 27. South America Hemocompatibility Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 28. South America Hemocompatibility Testing Service Sales Value by Country (%), 2024 VS 2031
Figure 29. Middle East & Africa Hemocompatibility Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 30. Middle East & Africa Hemocompatibility Testing Service Sales Value by Country (%), 2024 VS 2031
Figure 31. Key Countries/Regions Hemocompatibility Testing Service Sales Value (%), (2020-2031)
Figure 32. United States Hemocompatibility Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 33. United States Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 34. United States Hemocompatibility Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 35. Europe Hemocompatibility Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 36. Europe Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 37. Europe Hemocompatibility Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 38. China Hemocompatibility Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 39. China Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 40. China Hemocompatibility Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 41. Japan Hemocompatibility Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 42. Japan Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 43. Japan Hemocompatibility Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 44. South Korea Hemocompatibility Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 45. South Korea Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 46. South Korea Hemocompatibility Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 47. Southeast Asia Hemocompatibility Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 48. Southeast Asia Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 49. Southeast Asia Hemocompatibility Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 50. India Hemocompatibility Testing Service Sales Value, (2020-2031) & (US$ Million)
Figure 51. India Hemocompatibility Testing Service Sales Value by Type (%), 2024 VS 2031
Figure 52. India Hemocompatibility Testing Service Sales Value by Application (%), 2024 VS 2031
Figure 53. Hemocompatibility Testing Service Industrial Chain
Figure 54. Hemocompatibility Testing Service Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Hemocompatibility Testing Service market size from 2025 to 2031?
The annual compound growth rate of the global Hemocompatibility Testing Service market is 7.3% 2025 to 2031.
Which region is expected to have the highest market share?
Which companies rank high in the global Hemocompatibility Testing Service market?
What was the global market size of Hemocompatibility Testing Service in 2031?
What was the global market size of Hemocompatibility Testing Service in 2025?
Related Reports
Global Hemocompatibility Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemocompatibility Testing Service market is projected to grow from US$ 91 million in 2025 to US$ 148 million by 2032, at a CAGR of 7.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 149
USD 4900.00
(Single User License)
Global Hemocompatibility Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemocompatibility Testing Service market size was US$ 91 million in 2025 and is forecast to reach a readjusted size of US$ 148 million by 2032 with a CAGR of 7.3% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 101
USD 4250.00
(Single User License)
Hemocompatibility Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemocompatibility Testing Service was estimated to be worth US$ 91 million in 2025 and is projected to reach US$ 148 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 130
USD 3950.00
(Single User License)
Global Hemocompatibility Testing Service Market Research Report 2026
The global Hemocompatibility Testing Service market was valued at US$ 91 million in 2025 and is anticipated to reach US$ 148 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 129
USD 2900.00
(Single User License)
Global Hemocompatibility Testing Service Market Research Report 2025
The global market for Hemocompatibility Testing Service was valued at US$ 83.0 million in the year 2024 and is projected to reach a revised size of US$ 139 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published Date: 2025-06-07
Pages: 92
USD 2900.00
(Single User License)
Global Hemocompatibility Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemocompatibility Testing Service market size was US$ 83.0 million in 2024 and is forecast to a readjusted size of US$ 139 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-06-07
Pages: 107
USD 4250.00
(Single User License)
Global Hemocompatibility Testing Service Market Insights, Forecast to 2031
The global Hemocompatibility Testing Service market is projected to grow from US$ 91.0 million in 2025 to US$ 139 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period.
Published Date: 2025-06-07
Pages: 147
USD 4900.00
(Single User License)
Global Hemocompatibility Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemocompatibility Testing Service market is projected to grow from US$ 91 million in 2025 to US$ 148 million by 2032, at a CAGR of 7.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 149
USD 4900.00 (Single User License)Global Hemocompatibility Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemocompatibility Testing Service market size was US$ 91 million in 2025 and is forecast to reach a readjusted size of US$ 148 million by 2032 with a CAGR of 7.3% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 101
USD 4250.00 (Single User License)Hemocompatibility Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemocompatibility Testing Service was estimated to be worth US$ 91 million in 2025 and is projected to reach US$ 148 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-03-09
Pages: 130
USD 3950.00 (Single User License)Global Hemocompatibility Testing Service Market Research Report 2026
The global Hemocompatibility Testing Service market was valued at US$ 91 million in 2025 and is anticipated to reach US$ 148 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-03-09
Pages: 129
USD 2900.00 (Single User License)Global Hemocompatibility Testing Service Market Research Report 2025
The global market for Hemocompatibility Testing Service was valued at US$ 83.0 million in the year 2024 and is projected to reach a revised size of US$ 139 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published: 2025-06-07
Pages: 92
USD 2900.00 (Single User License)Global Hemocompatibility Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemocompatibility Testing Service market size was US$ 83.0 million in 2024 and is forecast to a readjusted size of US$ 139 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-06-07
Pages: 107
USD 4250.00 (Single User License)Global Hemocompatibility Testing Service Market Insights, Forecast to 2031
The global Hemocompatibility Testing Service market is projected to grow from US$ 91.0 million in 2025 to US$ 139 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period.
Published: 2025-06-07
Pages: 147
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now